Declaration of interest
The use of benzodiazepines has been advised against in older people, but prevalence rates remain high.
To review the evidence for interventions aimed at reducing benzodiazepine use in older people.
We conducted a systematic review, assessment of risk of bias and meta-analyses of randomised controlled trials of benzodiazepine withdrawal and prescribing interventions.
Ten withdrawal and eight prescribing studies met the inclusion criteria. At post-intervention, significantly higher odds of not using benzodiazepines were found with supervised withdrawal with psychotherapy (odds ratio (OR) = 5.06, 95% CI 2.68-9.57, P<0.00001) and withdrawal with prescribing interventions (OR = 1.43, 95% CI 1.02-2.02, P = 0.04) in comparison with the control interventions treatment as usual (TAU), education placebo, withdrawal with or without drug placebo, or psychotherapy alone. Significantly higher odds of not using benzodiazepines were also found for multifaceted prescribing interventions (OR = 1.37, 95% CI 1.10-1.72, P = 0.006) in comparison with control interventions (TAU and prescribing placebo).
Supervised benzodiazepine withdrawal augmented with psychotherapy should be considered in older people, although pragmatic reasons may necessitate consideration of other strategies such as medication review.
This research was supported by the Mental Health of Older Adults and Dementia Clinical Academic Group within King’s Health Partners Academic Health Sciences Centre at the Institute of Psychiatry, King’s College London and the South London and Maudsley National Health Service Foundation Trust.
- Royal College of Psychiatrists